The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial

Show other versions (1)

OBJECTIVES: Antiretroviral therapy (ART) during acute HIV infection (AHI) restricts the HIV reservoir, but additional interventions are necessary to induce a cure. Intravenous immunoglobulin (IVIG) is not HIV-specific but is safe and temporarily reduces the HIV reservoir in chronic HIV infection. We...

Full description

Bibliographic Details
Main Authors:	Tiraboschi, J, Ray, S, Patel, K, Teague, A, Pace, M, Phalora, P, Robinson, N, Hopkins, E, Meyerowitz, J, Wang, Y, Cason, J, Kaye, S, Sanderson, J, Klenerman, P, Fidler, S, Frater, J, Fox, J
Format:	Journal article
Language:	English
Published:	Wiley 2017

Similar Items

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
by: Tiraboschi, J, et al.
Published: (2017)

Lack of effect of Maraviroc intensification on blood and gut reservoir.
by: Tiraboschi, J, et al.
Published: (2016)

Enrichment of the HIV reservoir in CD32+CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression
by: Martin, GE, et al.
Published: (2017)

Tenofovir disoproxil fumarate fails to prevent HIV acquisition or the establishment of a viral reservoir: two case reports
by: Fox, J, et al.
Published: (2016)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
by: Foster, C, et al.
Published: (2017)

A cure for HIV: is it in sight?
by: Pace, M, et al.
Published: (2014)

Human MAIT cells respond to and suppress HIV-1
by: Phetsouphanh, C, et al.
Published: (2021)

Immunotherapeutic approaches to HIV cure and remission
by: Lee, MJ, et al.
Published: (2021)

Vedolizumab use and the associations between α4β7 expression and HIV reservoir in the gut during treated primary HIV infection
by: Thornhill, JP, et al.
Published: (2019)

Curing HIV by 'kick and kill': from theory to practice?
by: Pace, M, et al.
Published: (2019)

The Role of CD4+ T Follicular Helper Cells in HIV Infection: From the Germinal Center to the Periphery.
by: Thornhill, J, et al.
Published: (2017)

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype
by: Thornhill, J, et al.
Published: (2019)

A randomised controlled trial comparing the impact of Antiretroviral Therapy (ART) with a ‘Kick-and-Kill’ approach to ART alone on HIV reservoirs in individuals with primary HIV infection (PHI); RIVER trial
by: Fidler, S, et al.
Published: (2018)

Advancing the HIV cure agenda: the next 5 years.
by: Thornhill, J, et al.
Published: (2015)

HIV-1 drug resistance in primary infections in the UK.
by: Fidler, S, et al.
Published: (2001)

CD32-expressing CD4 T cells are phenotypically diverse and can contain proviral HIV DNA
by: Martin, G, et al.
Published: (2018)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
by: Gossez, M, et al.
Published: (2018)

Maintenance of Functional CD57+Cytolytic CD4+T Cells in HIV plus Elite Controllers
by: Phetsouphanh, C, et al.
Published: (2019)

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial
by: Fidler, S, et al.
Published: (2020)

A pilot evaluation of whole blood finger-prick sampling for point-of-care HIV viral load measurement: the UNICORN study
by: Fidler, S, et al.
Published: (2017)

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection
by: Martin, G, et al.
Published: (2017)

New approaches in HIV eradication research.
by: Frater, J
Published: (2011)

Characterisation of the HIV-1 reservoir and the potential for viral eradication
by: Williams, J, et al.
Published: (2014)

Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection.
by: Fox, J, et al.
Published: (2008)

HIV-1 Specific CD4 Responses in Primary HIV-1 Infection predict disease progression in the SPARTAC Trial
by: Frater, A, et al.
Published: (2013)

Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection
by: Hoffmann, M, et al.
Published: (2016)

The impact of vorinostat and therapeutic vaccine on gut HIV DNA: the RIVER gut study
by: Thornhill, J, et al.
Published: (2019)

Current understanding in HIV immunopathology and treatment.
by: Williams, J, et al.
Published: (2012)

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
by: Hurst, J, et al.
Published: (2015)

Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency
by: Hurst, T, et al.
Published: (2016)

Post-treatment and spontaneous HIV control
by: Martin, G, et al.
Published: (2018)

The impact of HIV-1 subtype on the clinical response on HAART.
by: Frater, J
Published: (2002)

Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection
by: Frater, J, et al.
Published: (2019)

Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.
by: Hamlyn, E, et al.
Published: (2012)

Structured observations reveal slow HIV-1 CTL escape
by: Roberts, H, et al.
Published: (2015)

The role of the gut mucosa in protection from HIV-1 in highly exposed persistently seronegative individuals (HEPS)
by: Fox, J, et al.
Published: (2009)

PREDICTING CLEARANCE OF ACUTE HCV IN HIV-POSITIVE PATIENTS
by: Thomson, E, et al.
Published: (2009)

Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection.
by: Yager, N, et al.
Published: (2013)

Development of a virus immunocapture method to determine cellular sources of replicating populations of HIV-1 in vivo
by: Gartner, K, et al.
Published: (2011)

HIV/AIDS. HLA leaves its footprints on HIV.
by: McMichael, A, et al.
Published: (2002)